Carbamazepine remains the first-line treatment for classical trigeminal neuralgia, but interest is growing in supportive therapies that may enhance treatment outcomes.
Research suggests that omega-3 fatty acids and methylcobalamin, the active form of vitamin B12, may support nerve health and improve pain control when used alongside standard therapy. Current evidence is encouraging, but larger studies are still needed before firm conclusions can be drawn.
This content is for educational purposes only and does not replace professional medical advice.